title: Infliximab induced skin and pulmonary sarcoidosis in a rheumatoid arthritis patient.
authors.forename: Séverine
authors.initials: S
authors.lastname: Josse
authors.forename: Nathalie
authors.initials: N
authors.lastname: Klemmer
authors.forename: Sophie
authors.initials: S
authors.lastname: Moreno-Swirc
authors.forename: Vincent
authors.initials: V
authors.lastname: Goëb
authors.forename: Thierry
authors.initials: T
authors.lastname: Lequerré
authors.forename: Olivier
authors.initials: O
authors.lastname: Vittecoq
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D017565:Sarcoidosis, Pulmonary / Q000139:chemically induced* / Q000473:pathology; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab